|Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe|
Providing the latest business, scientific, and regulatory news for the pharmaceutical and biotech industries.
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.
Understanding Biological Indicator Grow-Out Times
Biological indicators (BIs) are used globally to monitor the efficacy of sterilization processes for medical products (1–5). BIs contain high numbers—generally 104 to 106—of bacterial endo-spores that are highly resistant to the sterilization process for which they are designed. The spores are placed on or in a carrier material such as paper and packaged to protect the BI before as well as after sterilization and before culturing. BIs are useful for validation and routine monitoring of ethylene oxide, steam, dry heat, low temperature steam formaldehyde, vapor hydrogen peroxide, and related plasma sterilization systems.
In the United States, BIs sold for use in healthcare facilities are considered medical devices and are regulated by the US Food and Drug Administration good manufacturing practices (GMPs) as promulgated in the Quality System Regulation of 1996 (6). BIs sold to manufacturers of sterile medical products are considered manufacturing components. Regardless of the intended use, BIs must be manufactured under carefully controlled conditions to assure quality, reproducibility, and predictable performance (7).
Reducing biological indicator incubation time and the existing FDA protocol
How much incubation time is required to provide sufficient information to allow the user to make a correct decision regarding the acceptability of the sterilization process? In the mid-1980s, the FDA Center for Device and Radiological Health (CDRH) issued a protocol (hereafter termed the RIT [reduced incubation time] protocol) for BI manufacturers and users to follow to reduce the incubation time for BIs from the normal seven days to a shorter time based on the results of testing defined in the protocol (8). The RIT protocol requires manufacturers to expose 100 BIs from each of three lots to separate sterilization processes; the results of the exposure to the sterilization processes must result in 30 to 80 nonsterile BIs from each lot after incubation at the appropriate conditions for seven days. Achieving this outcome requires carefully-controlled reduced lethality (fractional) sterilization runs for which highly specialized sterilization equipment is often used.
As required, for each of the three lots tested, the number of nonsterile BIs after seven days of incubation was greater or equal to 30 and less than or equal to 80. For lots 2 and 3, the 97.0% criterion was met after one day of incubation; for lot 1, however, the 97.0% criterion was met after two days of incubation. Based upon these results, a reduction of incubation time from seven to two days is acceptable.
Application of the RIT protocol
Both users and manufacturers of BIs have voiced concerns about several aspects of this approach to qualifying a reduction
of incubation time for BIs:
This RIT protocol has not been widely accepted outside the United States. The International Standards Organization (ISO) BI working group of TC198 (WG04) has been directed to develop a new RIT protocol that will be acceptable to the global community (9).
Data presented in this paper are based on Geobacillus stearothermophilus self-contained BIs that have been exposed to fractional moist heat sterilization processes. We present these data for the development of a new approach to qualify a reduced incubation time based upon a detailed analysis of grow-out times for numerous lots of BIs exposed to fractional moist heat sterilization processes.
The wording of the current RIT protocol suggests that it only applies to BI manufacturers unless the user desires to apply the product in a manner other than that stated by the manufacturer. This protocol has been applied to users by some regulatory auditors and notified bodies. In such cases, users are required to expose BIs in specific product loads in production scale sterilizers. Successful execution of the RIT protocol in a production sterilizer is extremely difficult since the outcome of the sterilization exposure must result in at least 30 and no more than 80 BIs having surviving spores; i.e. nonsterile. It is important that the exposure of BIs for an RIT study be performed in a manner that ensures that they are statistical replicates. In a small research vessel, each of the 100 BIs is exposed to nearly identical sterilization conditions; in a production-scale sterilizer, there can be significant variability in exposure conditions. The less uniform conditions in the production-scale sterilizer, particularly when performing a reduced lethality exposure, can result in larger variability in the number of surviving colony-forming units (CFU) among the nonsterile BIs.
The application of the RIT protocol in this manner suggests that the sterilizer and the associated load of product in some way influence the grow-out time of spores exposed to a fractional sterilization process. There are no published data to support the notion that the molecular-level action of the sterilizing agent on the spore is influenced by the size of the sterilizer, the presence of product, or process variations that affect the rate of spore inactivation.
We should emphasize that inactivation of microorganisms by sterilizing agents generally follows first-order kinetics (10,11). In the case of BIs, spore death is the result of the destruction of a critical molecule or chemical reaction such that the spore can not develop into a replicating vegetative form (12–14). The longer a spore is exposed to a sterilization process without a lethal event, the more collateral (nonlethal) damage can occur. Collateral damage could affect the time required to complete germination and/or the time required for the vegetative cells to divide (generation time). Such germination- and generation-time effects could influence the time required to have a visible/chemical indication that a given BI had one or more surviving spores after exposure to a sterilizing agent.
D-value. Time or dose required to achieve inactivation of 90% of a population of the test microorganism under stated dose conditions (15).
Biological indicator (BI). A test system containing viable microorganisms providing a defined resistance to a specified sterilization process (15).
Most probable number (MPN). The estimated population of maximum likelihood responsible for producing the observed combination of positive and negative outcomes (16).
Sterility assurance level (SAL). the probability of a single viable microorganism occurring on an item after sterilization. Note that the term SAL takes a quantitative value, generally 10-6 or 10-3. When applying this quantitative value to assurance of sterility, a SAL of 10-6 has a lower value but provides a greater assurance of sterility than a SAL of 10-3 (15, 17).
The science of sterilization and disinfection has received considerable attention in the last 100 years (10, 11,13,18). Its importance was initially linked to an understanding of prevention and transmission of disease. Later, the consistent production of quality products such as wine, milk, and milk products became the emphasis. Significant strides were made in the last century in defining and predicting rates of microbial inactivation using the concept of decimal reduction values or D-values (18–20). As the science of sterilization was refined, it became necessary to be able to predict the surviving numbers of microbes as their population approached zero. Thus the probabilistic nature of microbial lethality and first order kinetics has become a well recognized applied science. One method of predicting low numbers of surviving microbes is the MPN approach of Halvorson and Ziegler (16). MPN gives an estimate of the average number of surviving spores per BI.
MPN is calculated using the formula:
MPN = ln (n ÷ r)
where n is the total number of units tested, and r is the number of sterile units.
The MPN approach can be applied to all fraction negative-type data (number tested/number nonsterile) as long as at least one of the replicate BIs is nonsterile. The MPN approach is generally applied over the range of 1% to 99% sterile BIs. The experimental design must ensure that all these BIs are statistical replicates.
The validity of the MPN approach for determination of inactivation rates and D-values has been affirmed by comparing results obtained by the survivor curve method (13, 19). D-values determined by the latter method generally agree well with those determined by the MPN approach.
For a set of 100 BIs exposed to a sterilization process where only one BI is found to be sterile, the average number of surviving spores is 4.605 as determined by the MPN calculation. In the cases of 80 and 30 nonsterile BIs out of 100 tested, the average number of survivors, as would be expected, is lower at 1.609 and 0.357, respectively. The cases of 80 and 30 nonsterile BIs per 100 tested are particularly relevant to a discussion of the RIT protocol.
If a set of 100 BIs is exposed to a sterilization process and 80 of the BIs are nonsterile, it is clear that 20 of the BIs have "0" surviving spores. The MPN calculation gives an average number of surviving spores of 1.609 or a total of~161 spores distributed across the 80 nonsterile BIs. The Poisson distribution analysis shows that ~32 of the BIs would be expected to have only one surviving spore and ~2 BIs would be expected to have five surviving spores. In the case where only 30 nonsterile BIs were found after an exposure to a sterilization process, 70 would have 0 spores and ~25 would be expected to have one surviving spore. In this case, a BI with five surviving spores would be very unlikely.
Germination and growth considerations
Out growth of a nonsterile BI is a function of:
Considerable research has been conducted with different sterilization methods that demonstrate that the processes can adversely impact spore germination (21). One could predict that for stressed populations of spores, delayed outgrowth would generally be the result of longer germination times rather than longer generation times. To result in the latter, a process must inflict an inherited mutation producing a rate-limiting effect on reproduction without it being a lethal mutation. However, many adverse effects on the spore coat, spore cortex, or ionic constitution, for example, have been shown to delay germination without resulting in longer generation times of the offspring (22). Therefore, merely on the basis of probability, one may conclude that most outgrowth delays result from delayed germination time.
Targeting an average number of one surviving spore per BI appears to be a crucial aspect of the RIT protocol; the 30 to 80 nonsterile BI "window" provides a MPN average of 0.357 to 1.609 spores per BI. Therefore, the protocol is suited to accomplish its intended purpose. When exposure to a sterilization process yields a BI with a single viable but possibly damaged spore, variations in grow-out time can be ascribed to the metabolic/genetic constitution of that spore. However, if multiple spores are present on an exposed BI, the resulting nonsterile outcome will be the result of the most rapid out-grower in the group. This is true whether the spore driving the nonsterile outcome does so by faster germination and conversion to a cell form, shorter generation time, or a combination of both. The fact that the outgrowth characteristics of individual spores can be masked when multiple spores survive on a given BI is important for the subsequent discussion here; BIs that exhibit prolonged grow-out times likely have one surviving but damaged spore.
Analysis of biological indicator incubation grow-out times
The following data were generated to form a basis for the analysis of BI grow-out time following exposure to a moist heat sterilization process; the analysis presented here is based on the results from testing approximately 4,000 BIs. Self-contained BIs (EZ-Test, SGM Biotech) inoculated with approximately 105 Geobacillus stearothermophilus spores were used.
Groups of 100 replicate BIs were exposed to a moist heat sterilization process designed to result in sterilization of only a fraction of the BIs with a target of 30 to 80 of the BIs per group to be nonsterile. For each group of 100 BIs, the average number of surviving spores was calculated by the MPN approach, and the number of BIs with 0,1,2,3,4,5,6,7,8,9, and 10 spores was estimated by a Poisson distribution analysis.
Table II gives the average number of surviving spores per BI and the Poisson distribution analysis for all possible experimental outcomes from 1 to 99 nonsterile BIs.
Materials and methods
A series of experiments were performed using an ISO 18472-compliant resistometer (23). Self-contained BIs produced from four separate Geobacillus stearothermophilus spore crops were tested. The four spore crops, ATCC #7953, were produced over a span of seven years. Fourteen distinct manufacturing lots of BIs were produced from these spore crops; these lots were produced over a span of approximately 18 months. All BI lots and resistance testing results met the requirements of ISO 11138-1:2006,11138-3:2006, and ANSI/AAMI ST79:2006 (4,7,24). For the sterilization exposures, BIs were selected randomly from the 14 production lots.
Groups of BIs were tested in the following manner:
1. Nine groups of 100 and two groups of 50 BIs were tested for sterility with no exposure to the moist heat sterilization process.
2. Ten groups of 100 BIs were exposed to a moist heat sterilization process targeted to result in approximately 300 surviving spores per BI. This number of surviving spores was chosen because it approximates the outcome of a "survival time" exposure as defined in USP 32 (5).
3. Eighteen groups of 100 BIs were exposed to moist heat sterilization processes targeting results of 30 to 80 nonsterile BIs per 100, the "window" in the RIT protocol.
SGM's Smart-Well system (60 + 2° C) was used to incubate the BIs and detect color change in the BI growth medium. When growth was detected, the system recorded the incubation time as hours:minutes; e.g. 2:53. All BIs in these experiments were incubated for a total of seven days.
Scatter plots of all of the grow-out times for each of the three sets of BIs are shown in Figure 3.
As can be seen in Figures 2 and 3, the BIs that were not exposed to moist heat sterilization (left panel of Figure 2 and bottom plot of Figure 3) exhibited the shortest overall grow-out times (time recorded by the incubator system when growth was detected) with relatively little intra- or inter-lot variability.
When the BIs were exposed to moist heat sterilization in a manner that resulted in ~300 surviving CFU/BI (center panel of Figure 2 and center plot of Figure 3), the overall grow-out times were somewhat increased with an apparent increase in intra-lot variability. The cause of the increase in grow-out time appears to be related to the lower number of surviving spores at the start of incubation. These BIs began incubation with ~300 CFU versus the ~105 CFU for the unexposed BIs, a difference of approximately nine generations.
MPN and poisson distribution analysis
Second, the grow-out times appear to follow a normal distribution for BIs with several hundred surviving CFU; BIs with few surviving CFU have more highly variable grow-out times with a measurable percentage exhibiting relatively long times before being scored as nonsterile. Of the ~1000 nonsterile BIs in the group where 30 to 80 of 100 were nonsterile after exposure, 10 BIs, or ~1%, exhibited a prolonged grow-out time (> 11 hours).
Third, the data support the hypothesis that delayed outgrowth of BIs is observed and limited to situations where a significant number or the majority of exposed BIs have only one surviving CFU.
John R. Gillis, PhD,* is president of SGM Biotech, Inc., 10 Evergreen Dr., Bozeman, MT 59715, firstname.lastname@example.org
*To whom all correspondence should be addressed.
Submitted: Nov. 13, 2009. Accepted: Dec. 7, 2009.
1. ISO 11135-1: 2007 (ISO, Geneva, 2006).
2. ISO 17665-1:2006 (ISO, Geneva, 2006).
3. ISO 14161:2000 (ISO, Geneva, 2000).
4. ANSI/AAMI ST79:2006 (AAMI, Arlington, VA, 2006).
5. USP 32–NF 27 General Chapter < 1211 >, "Sterilization and Sterility Assurance of Compendial Articles," 720–723.
6. FDA, 21 CFR Part 820: Quality System Regulation. Medical Devices: Current Good Manufacturing Practice (cGMP); Final Rule Oct. 7, 1996.
7. ISO 11138-1:2006 (ISO, Geneva, 2006).
8. CDRH, FDA Guide for Validation of Biological Indicator Incubation Time (Do. 98984, 2007).
9. The ISO/TC198/WG 04 Biological Indicator working group has been assigned a new work item proposal ISO/TS 16342 "Sterilization of healthcare products – Biological indicators – Method for validation of a reduced incubation time for a biological indicator."
10. H. Chick, J. Hygiene, 8, 92–158, (1908).
11. W. D. Bigelow, J. Inf. Dis., 29, 528–536 (1921).
12. O. Rahn, Biodynamica Monograph 3, Luyet, B. J., ed, (1945). Republished in Selected papers on the Microbiology and Engineering of Sterilization Processes, I. J. Pflug, ed. (Environmental Sterilization Laboratory, Minneapolis, 5th ed. 1988) pp. 1–16.
13. I.J. Pflug, Microbiology and Engineering of Sterilization Processes (Environmental Sterilization Services, Minneapolis, MN, 11th ed., 2003).
14. G.A. Mosley, BI & T, 36 (6), 451–454 (2003).
15. ISO TR11139:2006 (ISO, Geneva, 2006).
16. H.O. Halverson and N.R Ziegler, Journ. of Bacteriology 25, 101–121 (1933).
17. G. Mosley, Pharm Micro Forum Newsletter, 14 (5), (2008).
18. I.J. Pflug, R.G. Holcomb, and M.M. Gomez, "Thermal Destruction of Microorganisms," in Disinfection, Sterilization, and Preservation, ed. S. Block (Philadelphia: Lippincott, Williams & Wilkins, 2001) pp. 79-129.
19. L. I. Katzin,.A. Sanholzer, and M.E. Strong, J. Bacteriol., 45, 265–272 (1943).
20. C. R. Stumbo, J. R. Murphy, and J. Cochran, Food Technology, 4,321–326 (1950).
21. A. D. Russell, The Destruction of Bacterial Spores (Academic Press, London, 1982).
22. A. Hurst and G. W. Gould, The Bacterial Spore 2 (Academic Press, London, 1983).
23. ISO 18472:2006. (ISO, Geneva, 2006).
24. ISO 11138-3:2006. (ISO, Geneva, 2006).